Page last updated: 2024-08-24

plerixafor and Adjuvant Arthritis

plerixafor has been researched along with Adjuvant Arthritis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Billiau, A; Bridger, G; De Klerck, B; Geboes, L; Hatse, S; Kelchtermans, H; Matthys, P; Meyvis, Y; Schols, D; Vermeire, K	1
Billiau, A; Bridger, G; De Clercq, E; Hatse, S; Henson, GW; Matthys, P; Schols, D; Vermeire, K; Wuyts, A	1

Other Studies

2 other study(ies) available for plerixafor and Adjuvant Arthritis

Article	Year
Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis. Arthritis research & therapy, 2005, Volume: 7, Issue:6 Topics: Animals; Antibody Formation; Arthritis, Experimental; Benzylamines; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Chickens; Collagen Type II; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Immunity, Cellular; Interleukin-6; Joints; Male; Mice; Mice, Inbred DBA; Receptors, CXCR4	2005
AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice. Journal of immunology (Baltimore, Md. : 1950), 2001, Oct-15, Volume: 167, Issue:8 Topics: Animals; Arthritis, Experimental; Autoantigens; Autoimmune Diseases; Benzylamines; Chemokine CXCL12; Chemokines, CXC; Collagen Type II; Cyclams; Extremities; Heterocyclic Compounds; Hypersensitivity, Delayed; Interferon-gamma; Macrophage-1 Antigen; Mice; Mice, Inbred DBA; Mice, Knockout; Receptors, CXCR4	2001

Article

Year

Pro-inflammatory properties of stromal cell-derived factor-1 (CXCL12) in collagen-induced arthritis.

Arthritis research & therapy, 2005, Volume: 7, Issue:6

Topics: Animals; Antibody Formation; Arthritis, Experimental; Benzylamines; Cell Movement; Chemokine CXCL12; Chemokines, CXC; Chemotaxis; Chickens; Collagen Type II; Cyclams; Disease Models, Animal; Heterocyclic Compounds; Immunity, Cellular; Interleukin-6; Joints; Male; Mice; Mice, Inbred DBA; Receptors, CXCR4

2005

AMD3100, a potent and specific antagonist of the stromal cell-derived factor-1 chemokine receptor CXCR4, inhibits autoimmune joint inflammation in IFN-gamma receptor-deficient mice.

Journal of immunology (Baltimore, Md. : 1950), 2001, Oct-15, Volume: 167, Issue:8

Topics: Animals; Arthritis, Experimental; Autoantigens; Autoimmune Diseases; Benzylamines; Chemokine CXCL12; Chemokines, CXC; Collagen Type II; Cyclams; Extremities; Heterocyclic Compounds; Hypersensitivity, Delayed; Interferon-gamma; Macrophage-1 Antigen; Mice; Mice, Inbred DBA; Mice, Knockout; Receptors, CXCR4

2001